Warren Buffett’s Berkshire to buy Occidental’s chemical unit, shares jump over 2% on premarket Wall Street


Billionaire value investor Warren Buffett’s Omaha-based investment giant, Berkshire Hathaway, announced on Thursday, 2 October 2025, its plans to acquire Occidental Petroleum’s chemical business, OxyChem, according to an official release. The shares of the energy firm jumped over 2% during the pre-market trading session on Thursday.

Berkshire Hathaway plans to acquire Occidental’s chemical business in an all-cash transaction valued at $9.7 billion.

“Berkshire Hathaway (NYSE: BRK) and Occidental (NYSE: OXY) today announced a definitive agreement for Berkshire Hathaway to acquire Occidental’s chemical business, OxyChem, in an all-cash transaction for $9.7 billion, subject to customary purchase price adjustments,” according to the official release.

The global manufacturer of commodity chemicals aims to strengthen its financial position and capitalise on a ‘20+ years of low-cost resource runway’ to deliver long-term value for the investors.

“Berkshire is acquiring a robust portfolio of operating assets, supported by an accomplished team,” said Greg Abel, Vice Chairman of Non-Insurance Operations at Berkshire in the statement.

Occidental Petroleum Share Price Trend

Occidental Petroleum shares jumped 2.68% to $49 during the pre-market session on the New York Stock Exchange (NYSE), compared to $47.72 at the previous market close.

However, after the US stock market opened, the shares of the energy company dropped more than 3% to $46.26 as of 9:37 a.m. (EDT), compared to the previous Wall Street close, according to the data collected from MarketWatch.

(This is a developing story. Please check back for updates)

Read all stories by Anubhav mukherjee

Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.


Related Posts

In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

Amid rising geopolitical tensions and volatile global cues, Indian equity markets are witnessing a sharp reality check, reshaping investor sentiment and valuation dynamics. The recent correction, particularly in mid- and…

Stocks to buy under ₹100: Sumeet Bagadia recommends three stocks to buy on Monday – 23 March 2026

Indian stock market: The Indian stock market closed the week largely on a flat note with a slight negative bias, indicating underlying caution among participants. Sentiment remained positive in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cristiano Ronaldo’s 1000-goal chase is not an obsession, insists Portugal boss Roberto Martinez ahead of FIFA World Cup| Football News

  • By admin
  • March 22, 2026
  • 1 views
Cristiano Ronaldo’s 1000-goal chase is not an obsession, insists Portugal boss Roberto Martinez ahead of FIFA World Cup| Football News

Inside the 20,000-sq-ft Amritsar mansion that doubles as Ranveer Singh aka Hamza’s palatial bungalow in Dhurandhar 2 | Bollywood News

  • By admin
  • March 22, 2026
  • 2 views
Inside the 20,000-sq-ft Amritsar mansion that doubles as Ranveer Singh aka Hamza’s palatial bungalow in Dhurandhar 2 | Bollywood News

In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

  • By admin
  • March 22, 2026
  • 1 views
In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

What is Claude Code Channels, Anthropic’s take on OpenClaw-style AI agent setups? | Technology News

  • By admin
  • March 22, 2026
  • 1 views
What is Claude Code Channels, Anthropic’s take on OpenClaw-style AI agent setups? | Technology News

Mohsin Naqvi threatens legal action against international players choosing IPL 2026 over PSL: ‘2-3 have left’

  • By admin
  • March 22, 2026
  • 1 views
Mohsin Naqvi threatens legal action against international players choosing IPL 2026 over PSL: ‘2-3 have left’

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

  • By admin
  • March 22, 2026
  • 1 views
Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots